National Centre for Disease Informatics & Research, Indian Council of Medical Research, Bengaluru, Karnataka, India.
Indian J Med Res. 2022 Oct-Nov;156(4&5):598-607. doi: 10.4103/ijmr.ijmr_1821_22.
BACKGROUND & OBJECTIVES: Information on recent cancer statistics is important for planning, monitoring and evaluating cancer control activities. This article aims to provide an update on the cancer incidence estimates in India by sex, age groups and anatomical sites for the year 2022. METHODS: The National Cancer Registry Programme Report 2020, reported the cancer incidence from 28 Population-Based Cancer Registries (PBCRs) for the years 2012-2016. This was used as the basis to calculate cancer estimates in India. Information pertaining to the population at risk was extracted from the Census of India (2001 and 2011) for the estimation of age-sex stratified population. PBCRs were categorised into the respective State and regions of the country to understand the epidemiology of cancer. The age-specific incidence rate for each specific anatomical site of cancer was applied to the estimated population to derive the number of cancer cases in India for 2022. RESULTS: The estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427 (crude rate:100.4 per 100,000). In India, one in nine people are likely to develop cancer in his/her lifetime. Lung and breast cancers were the leading sites of cancer in males and females, respectively. Among the childhood (0-14 yr) cancers, lymphoid leukaemia (boys: 29.2% and girls: 24.2%) was the leading site. The incidence of cancer cases is estimated to increase by 12.8 per cent in 2025 as compared to 2020. INTERPRETATION & CONCLUSIONS: The cancer incidence is continuing to increase in India. The new estimates will be helpful in planning cancer prevention and control activities through the intervention of early detection, risk reduction and management.
背景与目的:了解癌症的最新统计数据对于规划、监测和评估癌症控制活动至关重要。本文旨在提供印度 2022 年按性别、年龄组和解剖部位划分的癌症发病率估计更新。
方法:国家癌症登记计划报告 2020 年报告了 28 个人口为基础的癌症登记处(PBCR)在 2012-2016 年期间的癌症发病率。这是计算印度癌症估计的基础。从印度人口普查(2001 年和 2011 年)中提取与风险人群相关的信息,用于估计年龄性别分层人口。根据该国的州和地区对 PBCR 进行分类,以了解癌症的流行病学。将每个特定解剖部位的癌症的年龄特异性发病率应用于估计的人口,以得出印度 2022 年的癌症病例数。
结果:印度 2022 年估计有 1461427 例新发病例(粗发病率:每 10 万人 100.4 例)。在印度,每九个人中就有一个人可能在一生中患上癌症。肺癌和乳腺癌分别是男性和女性中最常见的癌症部位。在儿童(0-14 岁)癌症中,淋巴白血病(男孩:29.2%,女孩:24.2%)是最常见的部位。与 2020 年相比,预计 2025 年癌症病例的发病率将增加 12.8%。
解释与结论:印度的癌症发病率仍在持续上升。新的估计将有助于通过早期发现、降低风险和管理等干预措施,规划癌症预防和控制活动。
Asian Pac J Cancer Prev. 2013
Epidemiol Prev. 2013
Asian Pac J Cancer Prev. 2013
Epidemiol Prev. 2016
Pharmaceuticals (Basel). 2025-8-13
JAMA Netw Open. 2025-8-1
Discov Oncol. 2025-8-11
Chin Med J (Engl). 2022-2-9
CA Cancer J Clin. 2022-1
Lancet Oncol. 2021-7
JCO Glob Oncol. 2020-7